A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: The International MGuard Prime Observational Study (IMOS Prime)

Catheterization and Cardiovascular Interventions

Volumn 86, Issue , 2015, Pages S28-S33

  Amoroso, Giovanni ^a   Vos, Nicola S ^a   Van Der Heyden, Jan A S ^b   Van Der Schaaf, Rene J ^a   Patterson, Mark S ^a   Vink, Maarten A ^a   Herrman, Jean Paul ^a   Slagboom, Ton ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

BMS; embolic protection; mesh stent; primary PCI; STEMI

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MGUARD PRIME EMBOLIC PROTECTION STENT; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; POSTMARKETING SURVEILLANCE; PROSPECTIVE STUDY; Q WAVE; REPERFUSION; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EMBOLIC PROTECTION DEVICE; EMBOLISM; FOLLOW UP; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSTHESIS DESIGN; RADIOGRAPHY; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EMBOLIC PROTECTION DEVICES; EMBOLISM; FOLLOW-UP STUDIES; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME;

EID: 84940947529     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25914     Document Type: Article

References (21)

1. Keeley EC, Boura JA, Grines CL., Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20
2. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ., Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome. Circulation 1999; 99: 1972-1977.
3. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AW, et al., Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-1117.
4. Inaba Y, Chen JA, Mehta N, Bergmann SR., Impact of single or multicentre study design on the results of trials examining the efficacy of adjunctive devices to prevent distal embolisation during acute myocardial infarction. EuroIntervention 2009; 5: 375-383.
5. Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, et al., Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: The INFUSE-AMI randomized trial. JAMA 2012; 307: 1817-1826.
6. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, et al., Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A randomized controlled trial. JAMA 2005; 293: 1063-1072.
7. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, et al., Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358: 557-567.
8. Stone GW, Abizaid A, Silber S, Dizon JM, Merkely B, et al., Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: The MASTER trial. J Am Coll Cardiol 2012; 60: 1975-1984.
9. Dudek D, Dziewierz A, Brener S, Abizaid A, Merkely B, Costa RA, Bar E, Rakowski T, Kornowski R, Dressler O, Silber S, Stone GW., Mesh-covered embolic protection stent implantation in ST-segment elevation myocardial infarction: Final one-year clinical and angiographic results from the MASTER trial. TCT 2013, oral abstract# 1067.
10. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, et al., Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009; 360: 1946-1959.
11. Dudek D, Dziewierz A, Kleczyński P, Giszterowicz D, Rakowski T, et al., Long-term follow-up of mesh-covered stent implantation in patients with ST-segment elevation myocardial infarction. Kardiol Pol 2014; 72: 140-145.
12. Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, et al., Mesh covered stent in ST-segment elevation myocardial infarction. EuroIntervention 2010; 6: 582-589.
13. Kaluski E, Hauptmann KE, Müller R, Tsai S, Klapholz M, Grube E., Coronary stenting with MGuard: First-in-man trial. J Invasive Cardiol 2008; 20: 511-515.
14. Zeymer U, Schroder R, Tebbe U, Molhoek GP, Wegscheider K, Neuhaus KL., Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial. Eur Heart J 2001; 22: 769-775.
15. Moreno R, Jimenez-Valero S, Sanchez-Recalde A, Galeote G, Calvo L, et al., Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: A meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents. EuroIntervention 2011; 6: 1003-1010.
16. Schulz S, Richardt G, Laugwitz KL, Mehran R, Gershlick AH, et al., Comparison of prasugrel and bivalirudin vs clopidogrel and heparin in patients with ST-segment elevation myocardial infarction: Design and rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 trial. Clin Cardiol 2014; 37: 270-276.
17. Caixeta A, Lansky AJ, Mehran R, Brener SJ, Claessen B, et al., Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: Results from the HORIZONS-AMI trial. EuroIntervention 2013; 9: 220-227.
18. Kirtane AJ, Sandhu P, Mehran R, McEntegart M, Cristea E, et al., Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy). Am J Cardiol 2014; 113: 36-43.
19. Farkouh ME, Reiffel J, Dressler O, Nikolsky E, Parise H, et al., Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: The HORIZONS-AMI ECG substudy report. Circ Cardiovasc Interv 2013; 6: 216-223.
20. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, et al., Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: Evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2013; 62: 496-504.
21. Taniwaki M, Stefanini GG, Räber L, Brugaletta S, Cequier A, Dik H, et al., Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: Insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials. EuroIntervention (in press).